Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
RecruitingNCT06392867Phase: NAStarted 2024-01-08
Summary
The United States Food and Drug Administration (FDA) approved intermittent theta-burst stimulation (iTBS) in 2018 as a form of repetitive transcranial magnetic stimulation (rTMS). Hospitals worldwide
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
The Hong Kong Polytechnic UniversityHong Kong, Hong Kong
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06392867